Ivacaftor | C24H28N2O3 - PubChem
Ivacaftor (VX 770, CAS Number: 873054-44-5) | Cayman Chemical
IJMS | Free Full-Text | Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatis
Frontiers | Comprehensive Analysis of Chemical Structures That Have Been Tested as CFTR Activating Substances in a Publicly Available Database CandActCFTR
Cystic fibrosis - Wikiwand
Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation | PLOS ONE
Ivacaftor carboxylate | C24H26N2O5 - PubChem
Design and Synthesis of Orally Bioavailable Piperazine Substituted 4(1H)-Quinolones with Potent Antimalarial Activity: Structure–Activity and Structure–Property Relationship Studies | Journal of Medicinal Chemistry
Lumacaftor/ivacaftor - Wikipedia
Case Study: Cystic Fibrosis
A Little CFTR Goes a Long Way: CFTR-Dependent Sweat Secretion from G551D and R117H-5T Cystic Fibrosis Subjects Taking Ivacaftor | PLOS ONE
Elexacaftor/tezacaftor/ivacaftor - Wikipedia
Lumacaftor/ivacaftor - Wikipedia
SYMKEVI (tezacaftor/ivacaftor) - Wiki | Golden
Structural identification of a hotspot on CFTR for potentiation | Science
The impact of ivacaftor on sinonasal pathology in S1251N-mediated cystic fibrosis patients | PLOS ONE
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects - Kelly Kuk, Jennifer L. Taylor-Cousar, 2015
ivacaftor | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Outcomes and Tolerances in Cystic Fibrosis Treatment Lumacaftor/Ivacaftor
Ivacaftor cystic fibrosis drug molecule. Stock Illustration | Adobe Stock
Ivacaftor - Wikipedia
Elexacaftor/tezacaftor/ivacaftor - Wikipedia
